Skip to main content
Premium Trial:

Request an Annual Quote

Michael Christman

Michael Christman, president and CEO of the Coriell Institute for Medical Research, has died. He joined Coriell in 2007 and founded the Coriell Personalized Medicine Collaborative, which studies the utility of genetics in medicine. He also co-founded pharmacogenomics company Coriell Life Sciences and served as chairman of its board of directors. Previously, he was a professor and founding chair of the Department of Genetics and Genomics at Boston University School of Medicine. Before that, he was an associate professor at the University of California, San Francisco. Christman held a doctorate in biochemistry from the University of California, Berkeley, and a bachelor's degree in chemistry from the University of North Carolina, Chapel Hill. He was also a postdoctoral fellow at the Massachusetts Institute of Technology.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.